VOYA Investment Management
RNAC icon

VOYA Investment Management’s Cartesian Therapeutics RNAC Stock Holding History

VOYA Investment Management’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,533
Closed -$29.9K – 2894
2024
Q1 		$29.9K Sell
1,533
-127
-8% -$2.69K ﹤0.01% 2767
2023
Q4 		$34.3K Hold
1,660
– – ﹤0.01% 2880
2023
Q3 		$52.8K Hold
1,660
– – ﹤0.01% 2849
2023
Q2 		$55.8K Buy
+1,660
New +$59.4K ﹤0.01% 2891
2022
Q2 		– Sell
-1,190
Closed -$44K – 2874
2022
Q1 		$44K Hold
1,190
– – ﹤0.01% 2608
2021
Q4 		$116K Sell
1,190
-11
-0.9% -$1.18K ﹤0.01% 2645
2021
Q3 		$150K Hold
1,201
– – ﹤0.01% 2654
2021
Q2 		$151K Buy
1,201
+189
+19% +$22.5K ﹤0.01% 2676
2021
Q1 		$137K Sell
1,012
-30
-3% -$3.72K ﹤0.01% 2620
2020
Q4 		$95K Buy
1,042
+256
+33% +$22.2K ﹤0.01% 2570
2020
Q3 		$58K Hold
786
– – ﹤0.01% 2420
2020
Q2 		$67K Buy
+786
New +$71.2K ﹤0.01% 2401
2019
Q2 		– Sell
-401
Closed -$29K – 2610
2019
Q1 		$29K Buy
+401
New +$25.4K ﹤0.01% 2531

Other funds holding RNAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

VOYA Investment Management's RNAC Position: Q2 2024 in Review

VOYA Investment Management sold out of Cartesian Therapeutics (RNAC) in Q2 2024, closing a stake of 1,533 shares — an estimated $29.9K sold.

VOYA Investment Management first reported a position in RNAC in Q1 2019 and held it in 13 quarters. The position peaked at $151K in Q2 2021. 61 funds tracked by Wall St. Rank hold RNAC as of Q2 2024.

  • VOYA Investment Management reported no remaining Cartesian Therapeutics position as of Q2 2024 after selling out during the quarter.
  • VOYA Investment Management sold 1,533 Cartesian Therapeutics shares in Q2 2024, an estimated $29.9K.
  • VOYA Investment Management first reported a position in Cartesian Therapeutics in Q1 2019 and held it in 13 quarters.
  • VOYA Investment Management's Cartesian Therapeutics position peaked at $151K in Q2 2021.
  • 61 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q2 2024.

Based on VOYA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.